Oxaliplatin News and Research

RSS
EMA CHMP adopts negative opinion for Amgen's Vectibix in treatment of wild-type KRAS metastatic colorectal cancer

EMA CHMP adopts negative opinion for Amgen's Vectibix in treatment of wild-type KRAS metastatic colorectal cancer

Sanofi-aventis, Regeneron announce results of VEGF Trap Phase III trial in second-line NSCLC

Sanofi-aventis, Regeneron announce results of VEGF Trap Phase III trial in second-line NSCLC

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

New long-term survival data from OPUS, CRYSTAL studies demonstrate strong tumor shrinkage of Erbitux

New long-term survival data from OPUS, CRYSTAL studies demonstrate strong tumor shrinkage of Erbitux

Genomic research could help doctors better target oxaliplatin drug to treat colorectal cancer patients: Study

Genomic research could help doctors better target oxaliplatin drug to treat colorectal cancer patients: Study

Oncolytics opens enrollment in REOLYSIN combination U.S. Phase I colorectal cancer study

Oncolytics opens enrollment in REOLYSIN combination U.S. Phase I colorectal cancer study

Choosing between EGFR therapeutic options in metastatic colorectal cancer

Choosing between EGFR therapeutic options in metastatic colorectal cancer

Oncothyreon commences combination PX-866/cetuximab Phase 1/2 trial in cancers

Oncothyreon commences combination PX-866/cetuximab Phase 1/2 trial in cancers

Phase 1b clinical trial of JX-594 in metastatic, refractory colorectal cancer commences in Korea

Phase 1b clinical trial of JX-594 in metastatic, refractory colorectal cancer commences in Korea

Erbitux development program featured in ASCO's Clinical Cancer Advances report for third consecutive year

Erbitux development program featured in ASCO's Clinical Cancer Advances report for third consecutive year

OSEO awards €10.4 million to DIPPAL project targeting Alzheimer's disease

OSEO awards €10.4 million to DIPPAL project targeting Alzheimer's disease

Oncolytics presents REO 013 clinical trial data for colorectal cancer at International Symposium in Spain

Oncolytics presents REO 013 clinical trial data for colorectal cancer at International Symposium in Spain

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

ACT Biotech reports positive interim data from Telatinib Phase 2 trial for advanced gastric cancer

ACT Biotech reports positive interim data from Telatinib Phase 2 trial for advanced gastric cancer

Amgen to present oncology portfolio results at ESMO Congress

Amgen to present oncology portfolio results at ESMO Congress

Merck Serono to present Erbitux data at ESMO Congress

Merck Serono to present Erbitux data at ESMO Congress

Amgen announces PRIME '203' and '181' Phase 3 trial results

Amgen announces PRIME '203' and '181' Phase 3 trial results

Flora Skeates represents Cancer Research UK in photographic exhibition at Oxo Tower

Flora Skeates represents Cancer Research UK in photographic exhibition at Oxo Tower

Aflibercept Phase 3 VELOUR clinical trial for mCRC to continue to completion

Aflibercept Phase 3 VELOUR clinical trial for mCRC to continue to completion